Objective Autoimmune pancreatitis (AIP) is a treatable form of chronic pancreatitis that has
been increasingly recognised over the last decade. We set out to better understand the …

Abstract Recently, IgG4-related disease (IgG4-RD) has been recognized as a novel clinical
entity with multiorgan involvement and unknown origin, associated with abundant infiltration …

OBJECTIVE. IgG4-related disease was not recognized as a specific clinical entity until 2003
when extrapancreatic lesions were reported in patients with autoimmune pancreatitis. IgG4 …

Background International consensus diagnostic criteria (ICDC) have been proposed to
classify autoimmune pancreatitis (AIP) in type 1, type 2, or not otherwise specified. Objective …

Some patients with autoimmune pancreatitis (AIP) form pancreatic stones suggestive of
transformation into chronic pancreatitis (CP). The present study examined the underlying …

Background Among many diagnostic criteria for autoimmune pancreatitis (AIP), the
International Consensus Diagnostic Criteria (ICDC) first enabled us to diagnose and …

AIM: To identify clinical and pathological differences between serum immunoglobulin G4
(IgG4)-positive (SIP) and IgG4-negative (SIN) type 1 autoimmune pancreatitis (AIP) in South …

Autoimmune pancreatitis (AIP) is a rare, heterogeneous, fibroinflammatory disorder of the
pancreas. It has gained increasing recognition due to a presentation that can mimic difficult …

Autoimmune pancreatitis (AIP) remains one of the rarer forms of pancreatitis but has become
increasingly well recognized and widely diagnosed as it is an important differential …

Background High serum immunoglobulin G4 (IgG4) levels and infiltration of IgG4-positive
cells are characteristic of Type 1 autoimmune pancreatitis (AIP). We previously reported that …